HIV prevention with drug-using populations--current status and future prospects: introduction and overview.
作者信息
Needle R H, Coyle S L, Normand J, Lambert E, Cesari H
机构信息
National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, Rockville, MD 20857, USA.
出版信息
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):4-18.
Abstract
摘要
相似文献
1
HIV prevention with drug-using populations--current status and future prospects: introduction and overview.
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):4-18.
2
HIV prevention with drug using populations. Current status and future prospects.
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):1-3.
3
The role of needle exchange programs in HIV prevention.
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):75-80.
4
Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):67-74.
5
Outreach-based HIV prevention for injecting drug users: a review of published outcome data.
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):19-30.
6
Women drug users and HIV prevention: overview of findings and research needs.
Women Health. 1998;27(1-2):19-23. doi: 10.1300/J013v27n01_02.
7
Moving from preventing HIV/AIDS in its infancy to preventing family illness and death (PFID).
Int J Infect Dis. 2008 Mar;12(2):117-9. doi: 10.1016/j.ijid.2007.09.006. Epub 2007 Nov 26.
8
Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions.
Am J Obstet Gynecol. 2007 Sep;197(3 Suppl):S3-9. doi: 10.1016/j.ajog.2007.06.048.
9
NIDA campaign to raise awareness of drug abuse--HIV connection.
Am Fam Physician. 2006 Jan 1;73(1):22.
10
Community-based outreach HIV intervention for street-recruited drug users in Madras, India.
Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):58-66.
引用本文的文献
1
Opioid recovery initiation: Pilot test of a peer outreach and modified Recovery Management Checkup intervention for out-of-treatment opioid users.
J Subst Abuse Treat. 2018 Mar;86:30-35. doi: 10.1016/j.jsat.2017.12.007. Epub 2017 Dec 19.
2
Effect of peer-led outreach activities on injecting risk behavior among male drug users in Haryana, India.
Harm Reduct J. 2014 Feb 4;11:3. doi: 10.1186/1477-7517-11-3.
3
HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.
Am Psychol. 2013 May-Jun;68(4):274-85. doi: 10.1037/a0032745.
4
Biomedical approaches to HIV prevention.
Alcohol Res Health. 2010;33(3):195-202.
5
Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial.
Subst Abuse Treat Prev Policy. 2012 Jan 10;7:1. doi: 10.1186/1747-597X-7-1.
6
The Risk Avoidance Partnership: Training Active Drug Users as Peer Health Advocates.
J Drug Issues. 2006 Jul 1;36(3):541-570. doi: 10.1177/002204260603600303.
7
Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.
J Urban Health. 2008 May;85(3):323-51. doi: 10.1007/s11524-007-9248-5. Epub 2008 Mar 15.
8
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.
J Urban Health. 2006 Jan;83(1):86-100. doi: 10.1007/s11524-005-9009-2.
9
Risk behaviors and HIV/AIDS prevention education among IDUs in drug treatment in Shanghai.
J Urban Health. 2005 Sep;82(3 Suppl 4):iv84-91. doi: 10.1093/jurban/jti110.
10
Developing an HIV intervention for indigent women substance abusers in the United States Virgin Islands.
J Urban Health. 2005 Sep;82(3 Suppl 4):iv74-83. doi: 10.1093/jurban/jti109.
本文引用的文献
1
Update: syringe-exchange programs--United States, 1996.
MMWR Morb Mortal Wkly Rep. 1997 Jun 20;46(24):565-8.
2
The relevance of social network concepts to sexually transmitted disease control.
Sex Transm Dis. 1996 Jan-Feb;23(1):24-9. doi: 10.1097/00007435-199601000-00007.
3
Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):282-9. doi: 10.1097/00042560-199607000-00008.
4
Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens.
J Infect Dis. 1996 Apr;173(4):997-1000. doi: 10.1093/infdis/173.4.997.
5
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
J Acquir Immune Defic Syndr (1988). 1993 Sep;6(9):1049-56.
6
Syringe and needle exchange to prevent HIV infection.
JAMA. 1994 Jun 15;271(23):1825-6; author reply 1826-7. doi: 10.1001/jama.271.23.1825a.
7
Modifying the process of treatment to meet the threat of AIDS.
Int J Addict. 1994 Nov;29(13):1739-52. doi: 10.3109/10826089409047959.
8
Sex, drugs, and syringe exchange in New York City: women's experiences.
J Am Med Womens Assoc (1972). 1995 May-Aug;50(3-4):109-14.
9
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium.
Am J Epidemiol. 1995 Oct 15;142(8):864-74. doi: 10.1093/oxfordjournals.aje.a117726.
10
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.
Am J Public Health. 1995 Nov;85(11):1531-7. doi: 10.2105/ajph.85.11.1531.
Zotero 插件